You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Immune-Stimulants and Immune Modulators
1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect

 

Online download statistics by month:

Online download statistics by month: December 2023 to June 2025

AbstractFullPdf
Dec 20232401
Jan 20245205
Feb 20244608
Mar 20243209
Apr 20241401
May 20244402
Jun 20246607
Jul 20242607
Aug 20241003
Sep 20244003
Oct 20241606
Nov 2024604
Dec 20244605
Jan 20253006
Feb 2025006
Mar 20250011
Apr 20250012
May 20250019
Jun 2025005
Total4520120